Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Lotus Ventures Inc LTTSF


Primary Symbol: C.J

Lotus Ventures Inc. is a Canada-based licensed cannabis producer and owner of the Lotus Cannabis Co. brand. The Company primarily cultivates cannabis flowers, which are sold in the wholesale, recreational, and medical markets across Canada. The Company owns and operates a 22,500 square foot indoor cannabis production facility in Armstrong, British Columbia and holds the licenses for cultivation and sale of cannabis in Canada. It has grown several cultivars, including the Keylime Kush, Black Blossom, Tranquil Elephantizer, and Kalifornia. Its Keylime Kush recreational portfolio includes 3.5 gram flower, 14 gram flower, and 3 x 0.5 gram pre-rolls. The Company sells its flagship product, the Keylime Kush, to over 300 retail stores across British Columbia and Ontario.


CSE:J - Post by User

Bullboard Posts
Comment by travddon Jun 28, 2019 4:51pm
67 Views
Post# 29874910

RE:RE:Agree, with a few on the board ....

RE:RE:Agree, with a few on the board ....It might take them a bit of time to ramp up to full capacity... it's not clear what capacity they're currently operating at... but once they are at full capacity, even if their costs per gram are double what's forecasted (which is extremely unlikely), they should be making money. That does not include the costs of expansion, because obviously that will be more than their profits. If the general and administrative costs stay relatively the same, $3.2 million per year (which is inflated due to the one time licensing consulting costs), forecasted costs of growing around $2.2 million per year, 1 million grams sold to Auxly @ $2.25 per gram, the other million sold @$6-7 per gram, they should have a net before taxes of $3 million to $4 million.
Bullboard Posts